Coloplast A/S (XETRA: CBHD) Stock Analysis & Fundamentals

CBHDColoplast A/S

XETRA · DE · Healthcare · Medical Instruments & Supplies · coloplast.com

58.28EUR-1.55%Mkt Cap: 14.28B $P/E: 35.541d ago

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Co…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$142.49BUSDP/E 45.6

EssilorLuxottica Societe anonyme

$80.53BUSDP/E 30.2

BDX

Becton, Dickinson and Company

$51.10BUSDP/E 32.5

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.90BUSDP/E 45.4

DIM

Sartorius Stedim Biotech

$20.62BUSDP/E 64.6

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

Solventum Corporation

$15.08BUSDP/E 10.8

COO

The Cooper Companies, Inc.

$14.85BUSDP/E 64.5

BAX

Baxter International Inc.

$13.77BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap14.28B $

Enterprise Value39.41B $

Revenue (TTM)30.48B $

Gross Profit19.86B $

Net Income (TTM)5.49B $

Revenue/Share135.30 USD

Last Price58.28 EUR

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees17.1K

CountryDE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINUS19624Y2000

Valuation

P/E (Trailing)35.54

P/E (Forward)—

PEG1.09

EV/EBITDA4.26

EV/Revenue1.29

P/S0.47

P/B7.62

EPS (TTM)1.25

EPS (Forward)—

52W Range

57.1254% of range59.28

52W High59.28 EUR

52W Low57.12 EUR

Profitability

Gross Margin67.59%

Oper. Margin25.69%

EBITDA Margin30.37%

Profit Margin18.69%

ROE28.16%

ROA10.51%

Growth

Revenue Growth2.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF3.01B $

CapEx (TTM)1.46B $

FCF Margin14.99%

FCF Yield32.00%

Net Debt25.17B $

Net Debt/EBITDA2.72

Balance Sheet

Debt/Equity1.26

Current Ratio1.75

Quick Ratio1.01

Book Value/Sh7.629 EUR

Cash/Share4.739 EUR

Dividends

Fwd Div Rate3.080 EUR

Trail. Div Rate23.00 EUR

Div. Yield5.49%

5Y Avg Yield2.74%

Payout Ratio246.25%

Ex-Div DateMay 18, 2026

Pay Date—

Splits

Last Split5:1

Split DateDec 19, 2012

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.207.37M

Float144.57M

Insiders29.79%

Institutions32.58%

Technical

SMA 5054.07 (+7.8%)

SMA 20062.47 (-6.7%)

Beta0.55

S&P 52W Chg20.80%

Avg Vol (30d)3.93K

Avg Vol (10d)1.49K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—